Fidasimtamab, referred to as DLTV – 1504, represents a innovative avenue in the fight against multiple myeloma. This therapy a targeted molecule designed to concurrently engage CD3-positive lymphocytes https://www.targetmol.com/compound/fidasimtamab
{Fidasimtamab: This Promising Option in Advanced Myeloma Therapy ?
Internet - 2 hours 47 minutes ago fidasimtamab-bispecific-878995
Web Directory Categories
Web Directory Search
New Site Listings